Merit Medical Systems’ (MMSI) Buy Rating Reiterated at BTIG Research

BTIG Research reissued their buy rating on shares of Merit Medical Systems (NASDAQ:MMSI) in a research note released on Tuesday,Benzinga reports. BTIG Research currently has a $105.00 price objective on the medical instruments supplier’s stock.

Other equities analysts also recently issued research reports about the company. JPMorgan Chase & Co. increased their price target on Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Wells Fargo & Company upped their price objective on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Compass Point set a $107.00 target price on shares of Merit Medical Systems in a research note on Monday, April 20th. Needham & Company LLC lifted their target price on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Finally, Weiss Ratings raised shares of Merit Medical Systems from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, August 3rd. Eight equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $100.00.

Merit Medical Systems Trading Down 0.8%

Shares of NASDAQ:MMSI opened at $90.50 on Tuesday. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $5.40 billion, a PE ratio of 37.40, a P/E/G ratio of 2.30 and a beta of 0.49. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.75. The firm has a fifty day moving average price of $74.53 and a 200 day moving average price of $72.12.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The company had revenue of $418.84 million during the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Analysts expect that Merit Medical Systems will post 3.81 EPS for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Whalen Wealth Management Inc. bought a new position in Merit Medical Systems during the second quarter worth $571,000. Algert Global LLC boosted its holdings in Merit Medical Systems by 119.7% in the 2nd quarter. Algert Global LLC now owns 42,710 shares of the medical instruments supplier’s stock valued at $2,962,000 after purchasing an additional 23,270 shares during the period. Ranger Investment Management L.P. bought a new stake in Merit Medical Systems in the 2nd quarter valued at $9,045,000. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Merit Medical Systems in the 2nd quarter worth $12,923,000. Finally, Globeflex Capital L P acquired a new stake in Merit Medical Systems in the 2nd quarter worth $87,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.